It is great to see you here. To see all contents of the website, please register or restore your access.
We believe you will come back gladly.
The partnership will bring the TaqPath Menu | GeneProof PCR Kits to market.
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market.
The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust supply chain and support systems.
The portfolio to be delivered by Thermo Fisher is comprised of 37 CE-IVD molecular diagnostic assays from ALPCO-GeneProof's portfolio, built on its innovative “one workflow” technology allowing for ease of use and compatibility with a wide range of qPCR instruments.
Thermo Fisher plans to release the TaqPath Menu | GeneProof PCR kits in phases beginning with a panel for bloodborne and sexually transmitted infections (STIs).
Additional panels for respiratory infections, transplant and immunocompromised infections, thrombotic mutations, and vector-borne diseases will follow.
Or join us for Happy Hour at our booth on Tues, July 25, 4-5 PM
In January 2023, GeneProof was one of the first companies in Europe to obtain the EU Quality Management…